Cited by 398Genomics and Chromatin DynamicsAcute Myeloid Leukemia ResearchRetinoids in leukemia and cellular processes

CCAAT Enhancer-Binding Protein (C/EBP) and AML1 (CBFα2) Synergistically Activate the Macrophage Colony-Stimulating Factor Receptor Promoter

Open access
Zhang, Dong-Er, Hetherington, Christopher J., Meyers, Shari, Rhoades, Kristina L., Larson, Christopher J., Chen, Hui-Min, Hiebert, Scott W., Tenen, Daniel G.·1996·Molecular and Cellular Biology

Abstract

Transcription factors play a key role in the development and differentiation of specific lineages from multipotential progenitors. Identification of these regulators and determining the mechanism of how they activate their target genes are important for understanding normal development of monocytes and macrophages and the pathogenesis of a common form of adult acute leukemia, in which the differentiation of monocytic cells is blocked. Our previous work has shown that the monocyte-specific expression of the macrophage colony-stimulating factor (M-CSF) receptor is regulated by three transcription factors interacting with critical regions of the M-CSF receptor promoter, including PU.1 and AML1.PU.1 is essential for myeloid cell development, while the AML1 gene is involved in several common leukemia-related chromosome translocations, although its role in hematopoiesis has not been fully identified. Along with AML1, a third factor, Mono A, interacts with a small region of the promoter which can function as a monocyte-specific enhancer when multimerized and linked to a heterologous basal promoter. Here, we demonstrate by electrophoretic mobility shift assays with monocytic nuclear extracts, COS-7 cell-transfected factors, and specific antibodies that the monocyte-enriched factor Mono A is CCAAT enhancer-binding protein (C/EBP). C/EBP has been shown previously to be an important transcription factor involved in hepatocyte and adipocyte differentiation; in hematopoietic cells, C/EBP is specifically expressed in myeloid cells. In vitro binding analysis reveals a physical interaction between C/EBP and AML1. Further transfection studies show that C/EBP and AML1 in concert with the AML1 heterodimer partner CBF beta synergistically activate M-CSF receptor by more then 60 fold. These results demonstrate that C/EBP and AML1 are important factors for regulating a critical hematopoietic growth factor receptor, the M-CSF receptor, suggesting a mechanism of how the AML1 fusion protein could contribute to acute myeloid leukemia. Furthermore, they demonstrate physical and functional interactions between AML1 and C/EBP transcription factor family members.

Integrity signals

Registry

Crossref · 10.1128/mcb.16.3.1231

Cites

84 of 91 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

The text we found for this paper looks like another document, so its claims and self-check weren’t run. The registry and citation checks still apply.

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The text we found for this paper looks like another document, so the self-check wasn’t run.

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Zhang, D.-E., Hetherington, C. J., Meyers, S., Rhoades, K. L., Larson, C. J., Chen, H.-M., Hiebert, S. W., & Tenen, D. G.
Affiliations
  • Harvard University (US)
  • St. Jude Children's Research Hospital (US)
  • Salk Institute for Biological Studies (US)
  • Division of Hematology/Oncology, Department of Medicine, Beth Israel Hospital and Harvard Medical School, Boston, Massachusetts 02215
Venue
Molecular and Cellular Biology
Published
1996-03-01
Volume
16
Issue
3
Pages
1231-1240
ISSN
  • 0270-7306 (ISSN-L)
  • 1098-5549
OpenAlex
W2165787335
Cited by
396
References
82
Citations by year
2026: 3 · 2025: 4 · 2024: 3 · 2023: 10 · 2022: 7 · 2021: 3 · 2020: 2 · 2019: 8 · 2018: 9 · 2017: 14 · 2016: 7 · 2015: 7 · 2014: 10 · 2013: 11 · 2012: 8
FWCI
10.87
Type
journal article
Language
en
Open access
Locations
  • Molecular and Cellular Biology (publishedVersion)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
Funders
  • McKnight Foundation
  • St. Jude Children's Research Hospital (CA21765)
  • American Lebanese Syrian Associated Charities (CA 21765)
  • National Institutes of Health (CA21765))
  • National Cancer Institute (CA64140, CA 41456, CA/AI59589, R01CA041456, R01CA064140, P30CA021765)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Genomics and Chromatin Dynamics
  • Health Sciences › Medicine › Hematology › Acute Myeloid Leukemia Research
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Retinoids in leukemia and cellular processes
Keywords
C/EBP, RUNX1, macrophage colony-stimulating factor receptor, transcriptional activation, CBFβ, monocyte differentiation, acute myeloid leukemia, PU.1, hematopoietic transcription factors
MeSH terms
Animals, Base Sequence, Cell Line, DNA-Binding Proteins, Humans, Molecular Sequence Data, Monocytes, Neoplasm Proteins, Nuclear Proteins, Promoter Regions, Genetic, Protein Binding, Proto-Oncogene Proteins, Transcription Factors, Signal Transduction, Receptor, Macrophage Colony-Stimulating Factor, CCAAT-Enhancer-Binding Proteins, Core Binding Factor Alpha 2 Subunit

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review